Publicaciones en las que colabora con María Mercedes Garayoa Berrueta (22)

2021

  1. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

    Nature Communications, Vol. 12, Núm. 1

2017

  1. The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care

    Clinical Cancer Research, Vol. 23, Núm. 1, pp. 225-238

2014

  1. Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines

    PLoS ONE, Vol. 9, Núm. 3

  2. Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone disease

    Clinical Cancer Research, Vol. 20, Núm. 6, pp. 1542-1554

2013

  1. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598

2012

  1. CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

    Haematologica, Vol. 97, Núm. 7, pp. 1110-1114

2006

  1. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis

    American Journal of Pathology, Vol. 168, Núm. 1, pp. 280-291

  2. Adrenomedullin: An Esoteric Juggernaut of Human Cancers

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 453-458

2005

  1. Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 288, Núm. 3 32-3

2004

  1. Depressed adrenomedullin in the embryonic transforming growth factor-β1 null mouse becomes elevated postnatally

    International Journal of Developmental Biology, Vol. 48, Núm. 1, pp. 67-70

  2. Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement

    Cancer Research, Vol. 64, Núm. 17, pp. 6310-6318

  3. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients

    Clinical Cancer Research, Vol. 10, Núm. 11, pp. 3639-3649

2003

  1. Androgen-independent expression of adrenomedullin and peptidylglycine α-amidating monooxygenase in human prostatic carcinomoa

    Molecular Carcinogenesis, Vol. 38, Núm. 1, pp. 14-24

  2. Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury

    American Journal of Respiratory and Critical Care Medicine, Vol. 168, Núm. 3, pp. 287-296

  3. Leptin expression in the rat ovary depends on estrous cycle

    Journal of Histochemistry and Cytochemistry, Vol. 51, Núm. 10, pp. 1269-1277

2002

  1. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis

    Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 110-119

  2. Adrenomedullin in mammalian embryogenesis

    Microscopy Research and Technique, Vol. 57, Núm. 1, pp. 40-54

  3. The effects of adrenomedullin overexpression in breast tumor cells

    Journal of the National Cancer Institute, Vol. 94, Núm. 16, pp. 1226-1237

2000

  1. Expression of proadrenomedullin derived peptides in the mammalian pituitary: Co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes

    Journal of Neuroendocrinology, Vol. 12, Núm. 7, pp. 607-617

  2. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis

    Molecular Endocrinology, Vol. 14, Núm. 6, pp. 848-862